AGADA Biosciences provides orphan drug development services and drug testing for neuromuscular disorders.
AGADA Biosciences has raised $422K in total funding. The most recent round was Grant. The last funding was announced in March 2026.
AGADA Biosciences's investors include Innovacorp, Atlantic Canada Opportunities Agency.
AGADA Biosciences is headquartered in Halifax, Canada.
AGADA Biosciences provides orphan drug development services and drug testing for neuromuscular disorders.
AGADA Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AGADA Biosciences — Funding & Investors." VCBacked, March 3, 2026, https://www.vcbacked.co/company/agada-biosciences. Accessed July 21, 2026.
VCBacked. (2026). AGADA Biosciences — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/agada-biosciences
{{cite web |title=AGADA Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/agada-biosciences |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated